273 related articles for article (PubMed ID: 7686128)
1. [Clinical significance of antibody to Y19 protein in nonA and nonB chronic liver disease].
Sakashita H
Fukuoka Igaku Zasshi; 1993 Apr; 84(4):159-72. PubMed ID: 7686128
[TBL] [Abstract][Full Text] [Related]
2. Significance of specific antibody assay for genotyping of hepatitis C virus.
Tanaka T; Tsukiyama-Kohara K; Yamaguchi K; Yagi S; Tanaka S; Hasegawa A; Ohta Y; Hattori N; Kohara M
Hepatology; 1994 Jun; 19(6):1347-53. PubMed ID: 7514558
[TBL] [Abstract][Full Text] [Related]
3. A comparison of the prevalence of autoantibodies in individuals with chronic hepatitis C and those with autoimmune hepatitis: the role of interferon in the development of autoimmune diseases.
Bayraktar Y; Bayraktar M; Gurakar A; Hassanein TI; Van Thiel DH
Hepatogastroenterology; 1997; 44(14):417-25. PubMed ID: 9164512
[TBL] [Abstract][Full Text] [Related]
4. Hepatitis C virus infection in volunteer blood donors in Taiwan. Evaluation by hepatitis C antibody assays and the polymerase chain reaction.
Wang JT; Wang TH; Sheu JC; Tsai SJ; Hsieh YS; Lin DT; Wang CY; Chen DS
Arch Pathol Lab Med; 1993 Feb; 117(2):152-6. PubMed ID: 8381269
[TBL] [Abstract][Full Text] [Related]
5. [Virological studies on the usefulness of anti-HCV ELISA assay using recombinant N-14 fusion protein in various liver diseases].
Imamura S
Fukuoka Igaku Zasshi; 1993 Apr; 84(4):138-47. PubMed ID: 7686126
[TBL] [Abstract][Full Text] [Related]
6. [Enzyme-linked immunosorbent assay for antibodies against core protein of hepatitis C virus with a synthetic oligopeptide].
Sugiyasu T
Fukuoka Igaku Zasshi; 1993 Apr; 84(4):148-58. PubMed ID: 7686127
[TBL] [Abstract][Full Text] [Related]
7. Quantitative analysis of antibodies to hepatitis C virus during interferon-alpha therapy.
Yuki N; Hayashi N; Hagiwara H; Takehara T; Katayama K; Kasahara A; Fusamoto H; Kamada T
Hepatology; 1993 Jun; 17(6):960-5. PubMed ID: 7685734
[TBL] [Abstract][Full Text] [Related]
8. Interferon therapy in HCV-positive mixed cryoglobulinaemia: viral and host factors contributing to efficacy of the therapy.
Mazzaro C; Carniello GS; Colle R; Doretto P; Mazzi G; Crovatto M; Santini GF; Tulissi P; Gregoretti M; Mazzoran L; Russo A; Silvestri F; Pozzato G
Ital J Gastroenterol Hepatol; 1997 Aug; 29(4):343-50. PubMed ID: 9476189
[TBL] [Abstract][Full Text] [Related]
9. Detection of serum hepatitis C virus RNA in HCV antibody-seropositive volunteer blood donors.
McGuinness PH; Bishop GA; Lien A; Wiley B; Parsons C; McCaughan GW
Hepatology; 1993 Sep; 18(3):485-90. PubMed ID: 7689526
[TBL] [Abstract][Full Text] [Related]
10. Chronic hepatitis C virus infection in renal transplant: treatment and outcome.
Sharma RK; Bansal SB; Gupta A; Gulati S; Kumar A; Prasad N
Clin Transplant; 2006; 20(6):677-83. PubMed ID: 17100715
[TBL] [Abstract][Full Text] [Related]
11. Enzyme-linked immunosorbent assay for antibodies against the capsid protein of hepatitis C virus with a synthetic oligopeptide.
Okamoto H; Munekata E; Tsuda F; Takahashi K; Yotsumoto S; Tanaka T; Tachibana K; Akahane Y; Sugai Y; Miyakawa Y
Jpn J Exp Med; 1990 Aug; 60(4):223-33. PubMed ID: 1963454
[TBL] [Abstract][Full Text] [Related]
12. Immunoglobulin M antibody to hepatitis C virus core antigen: correlations with viral replication, histological activity, and liver disease outcome.
Quiroga JA; van Binsbergen J; Wang CY; Pardo M; Navas S; Trines C; Herrero M; CarreƱo V
Hepatology; 1995 Dec; 22(6):1635-40. PubMed ID: 7489967
[TBL] [Abstract][Full Text] [Related]
13. Studies of the effectiveness of interferon alpha treatment for chronic hepatitis C in children.
Czerwionka-Szaflarska M; Chrobot A; Szaflarska-Szczepanik A
Med Sci Monit; 2000; 6(5):964-70. PubMed ID: 11208439
[TBL] [Abstract][Full Text] [Related]
14. [Clinical significance of N-14 antibody (ELISA) in diagnosis of non-A, non-B liver disease].
Yone Y
Fukuoka Igaku Zasshi; 1992 Apr; 83(4):156-67. PubMed ID: 1318860
[TBL] [Abstract][Full Text] [Related]
15. Choice of appropriate end points of response to interferon therapy in chronic hepatitis C virus infection.
Davis GL; Lau JY
J Hepatol; 1995; 22(1 Suppl):110-4. PubMed ID: 7602061
[TBL] [Abstract][Full Text] [Related]
16. Detection of antigens related to hepatitis C virus RNA encoding the NS5 region in the livers of patients with chronic type C hepatitis.
Tsutsumi M; Urashima S; Takada A; Date T; Tanaka Y
Hepatology; 1994 Feb; 19(2):265-72. PubMed ID: 7507461
[TBL] [Abstract][Full Text] [Related]
17. Recombinant interferon-alpha and ursodeoxycholic acid versus interferon-alpha alone in the treatment of chronic hepatitis C: a randomized clinical trial with long-term follow-up.
Angelico M; Gandin C; Pescarmona E; Rapicetta M; Del Vecchio C; Bini A; Spada E; Baroni CD; Capocaccia L
Am J Gastroenterol; 1995 Feb; 90(2):263-9. PubMed ID: 7847298
[TBL] [Abstract][Full Text] [Related]
18. The significance of immunoglobulin M antibody response to hepatitis C virus core protein in patients with chronic hepatitis C.
Yuki N; Hayashi N; Ohkawa K; Hagiwara H; Oshita M; Katayama K; Sasaki Y; Kasahara A; Fusamoto H; Kamada T
Hepatology; 1995 Aug; 22(2):402-6. PubMed ID: 7543432
[TBL] [Abstract][Full Text] [Related]
19. Detection of hepatitis C virus sequences in liver tissue by the polymerase chain reaction.
Shieh YS; Shim KS; Lampertico P; Balart LA; Jeffers LJ; Thung SN; Regenstein F; Reddy KR; Farr G; Schiff ER
Lab Invest; 1991 Oct; 65(4):408-11. PubMed ID: 1656140
[TBL] [Abstract][Full Text] [Related]
20. [Summary and evaluation of genome and antibody diagnosis in hepatitis C virus infection].
Nishizono A
Rinsho Byori; 1994 Dec; 42(12):1240-7. PubMed ID: 7532727
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]